首页> 美国卫生研究院文献>Annals of the Rheumatic Diseases >Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

【2h】

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

机译：柳氮磺吡啶在未分化型脊柱关节炎和早期强直性脊柱炎引起的炎性背痛患者中的疗效：一项多中心随机对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesTo assess the effect of sulfasalazine (SSZ) on inflammatory back pain (IBP) due to active undifferentiated spondyloarthritis (uSpA) or ankylosing spondylitis in patients with symptom duration <5 years.

机译：目的评估柳氮磺胺吡啶（SSZ）对症状持续时间<5年的患者因活动性未分化脊椎关节炎（uSpA）或强直性脊柱炎引起的炎性背痛（IBP）的影响。

著录项

期刊名称 Annals of the Rheumatic Diseases
作者
J Braun; J Zochling; X Baraliakos; R Alten; G Burmester; K Grasedyck; J Brandt; H Haibel; M Hammer; A Krause; F Mielke; H‐P Tony; W Ebner; B Gömör; J Hermann; H Zeidler; E Beck; M Baumgaertner; J Sieper;
展开▼
作者单位

展开▼
年(卷),期 2006(65),9
年度 2006
页码 1147–1153
总页数 7
原文格式 PDF
正文语种
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial [J] . van der Heijde Desiree, Song In-Ho, Pangan Aileen L., The Lancet . 2019,第10214期

机译：upadacitinib在有源强直性脊柱炎患者中的疗效和安全性（选择轴1）：多期，随机，双盲，安慰剂控制，第2/3阶段试验
2. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseasemodifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial [J] . van der Heijde Desiree, Wei James Cheng-Chung, Dougados Maxime, The Lancet . 2018,第10163期

机译：Ixekizumab，一种白细胞介素-17A拮抗剂，治疗脊柱膜炎或射线摄影轴向脊椎动物，以前未经生物减少抗风湿药物（Coast-V）：16周的第3期随机，双盲，主动控制的结果和安慰剂对照试验
3. IS 25MG ETANERCEPT EFFECTIVE IN MAINTAINING A CLINICAL RESPONSE IN PATIENTS WITH ANKYLOSING SPONDYLITIS WHO HAVE RESPONDED TO 50MG ONCE WEEKLY: A MULTICENTRE RANDOMISED CONTROLLED TRIAL [J] . Elender F., Hamilton L., Yates M., Clinical and experimental rheumatology . 2014,第5期

机译：25mg止痛药可有效维持每周一次已应答50mg的强直性脊柱炎的患者的临床反应：多中心随机对照试验
4. Collecting Visual Analogue Scales and Health Assessment of Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Using an USB Controller [C] . Jaana Suhonen, Keijo Haataja, Niina Paivinen, IEEE/IFIP International Conference in Central Asia on Internet . 2008

机译：利用USB控制器收集类风湿性关节炎患者的视觉模拟规模和健康评估和强直性脊柱炎
5. Altered CD8+ T Cell Function in Ankylosing Spondylitis: The Role of Perforin in Enhanced Inflammatory Profiles [D] . Yao, YuChen. 2018

机译：强直性脊柱炎中改变的CD8 + T细胞功能：穿孔素在增强炎症反应中的作用
6. Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre randomised placebo-controlled study [O] . Oliver Hendricks, Tonny Elmose Andersen, Afshin Ashouri Christiansen, 2019

机译：大麻二酚的疗效和安全性然后采用四氢大麻酚的开放标签附加剂治疗类风湿关节炎或强直性脊柱炎患者的慢性疼痛：一项多中心随机安慰剂对照研究的方案
7. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial [O] . Braun, J, Zochling, J, Baraliakos, X, 2006

机译：柳氮磺吡啶在未分化型脊柱关节炎和早期强直性脊柱炎引起的炎性背痛患者中的疗效：一项多中心随机对照试验

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

摘要

著录项

相似文献

相关主题

期刊订阅